14 Hrkach J, von Hoff D, Ali M M, et al. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med, 2012, 4: 128-139
[2]
74 Sun Y, Yan X, Yuan T, et al. Disassemblable micelles based on reduction-degradable amphiphilic graft copolymers for intracellular delivery of doxorubicin. Biomaterials, 2010, 31: 7124-7131
[3]
11 Yamamoto Y, Hyodo I, Takigahira M, et al. Effect of combined treatment with the epirubicin-incorporating micelles (NC-6300) and 1,2-diaminocyclohexane platinum(II)-incorporating micelles (NC-4016) on a human gastric cancer model. Int J Cancer, 2014, 135: 214-223
[4]
12 Harada M, Bobe I, Saito H, et al. Improved anti-tumor activity of stabilized anthracycline polymeric micelle formulation, NC-6300. Cancer Sci, 2011, 102: 192-199
[5]
13 Takahashi A, Yamamoto Y, Yasunaga M, et al. NC-6300, an epirubicin-incorporating micelle, extends the antitumor effect and reduces the cardiotoxicity of epirubicin. Cancer Sci, 2013, 104: 920-925
[6]
15 Cabral H, Kataoka K. Progress of drug-loaded polymeric micelles into clinical studies. J Control Release, 2014, 190: 465-476
[7]
16 Jain R K, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol, 2010, 7: 653-664
[8]
17 Lammers T, Kiessling F, Hennink W E, et al. Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress. J Control Release, 2012, 161: 175-187
[9]
18 Bae Y H, Yin H. Stability issues of polymeric micelles. J Control Release, 2008, 131: 2-4
[10]
19 Read E S, Armes S P. Recent advances in shell cross-linked micelles. Chem Commun, 2007, (29): 3021-3035
[11]
20 Bae Y, Kataoka K. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv Drug Deliver Rev, 2009, 61: 768-784
[12]
21 Holback H, Yeo Y. Intratumoral drug delivery with nanoparticulate carriers. Pharm Res, 2011, 28: 1819-1830
[13]
22 Gullotti E, Yeo Y. Extracellularly activated nanocarriers: A new paradigm of tumor targeted drug delivery. Mol Pharm, 2009, 6: 1041-1051
[14]
23 Oerlemans C, Bult W, Bos M, et al. Polymeric micelles in anticancer therapy: Targeting, imaging and triggered release. Pharm Res, 2010, 27: 2569-2589
[15]
24 Lammers T, Subr V, Ulbrich K, et al. Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy. Nano Today, 2010, 5: 197-212
[16]
25 Rijcken C J, Snel C J, Schiffelers R M, et al. Hydrolysable core-crosslinked thermosensitive polymeric micelles: Synthesis, characterisation and in vivo studies. Biomaterials, 2007, 28: 5581-5593
[17]
26 Iijima M, Nagasaki Y, Okada T, et al. Core-polymerized reactive micelles from heterotelechelic amphiphilic block copolymers. Macromolecules, 1999, 32: 1140-1146
[18]
27 Shuai X T, Merdan T, Schaper A K, et al. Core-cross-linked polymeric micelles as paclitaxel carriers. Bioconjugate Chem, 2004, 15: 441-448
[19]
28 Ding J, Zhuang X, Xiao C, et al. Preparation of photo-cross-linked pH-responsive polypeptide nanogels as potential carriers for controlled drug delivery. J Mater Chem, 2011, 21: 11383-11391
[20]
29 Yan L, Yang L, He H, et al. Photo-cross-linked mPEG-poly(gamma-cinnamyl-L-glutamate) micelles as stable drug carriers. Polym Chem, 2012, 3: 1300-1307
[21]
30 Rodriguez-Hernandez J, Babin J, Zappone B, et al. Preparation of shell cross-linked nano-objects from hybrid-peptide block copolymers. Biomacromolecules, 2005, 6: 2213-2220
[22]
31 Xiong J, Meng F, Wang C, et al. Folate-conjugated crosslinked biodegradable micelles for receptor-mediated delivery of paclitaxel. J Mater Chem, 2011, 21: 5786-5794
[23]
32 Yang R, Meng F, Ma S, et al. Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(epsilon-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel. Biomacromolecules, 2011, 12: 3047-3055
[24]
33 Jiang Y, Chen J, Deng C, et al. Click hydrogels, microgels and nanogels: Emerging platforms for drug delivery and tissue engineering. Biomaterials, 2014, 35: 4969-4985
[25]
34 Chen W, Zheng M, Meng F, et al. In situ forming reduction-sensitive degradable nanogels for facile loading and triggered intracellular release of proteins. Biomacromolecules, 2013, 14: 1214-1222
[26]
35 Kang N, Perron M E, Prud'homme R E, et al. Stereocomplex block copolymer micelles: Core-shell nanostructures with enhanced stability. Nano Lett, 2005, 5: 315-319
[27]
36 Carstens M G, Bevernage J J L, van Nostrum C F, et al. Small oligomeric micelles based on end group modified mPEG-oligocaprolactone with monodisperse hydrophobic blocks. Macromolecules, 2007, 40: 116-122
[28]
37 Meng F, Cheng R, Deng C, et al. Intracellular drug release nanosystems. Mater Today, 2012, 15: 436-442
[29]
38 Ge Z, Liu S. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance. Chem Soc Rev, 2013, 42: 7289-7325
[30]
39 Meng F, Zhong Y, Cheng R, et al. pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: Concept and recent advances. Nanomedicine, 2014, 9: 487-499
[31]
40 Bae Y, Fukushima S, Harada A, et al. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change. Angew Chem Int Ed, 2003, 42: 4640-4643
[32]
41 Bae Y, Nishiyama N, Kataoka K. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjugate Chem, 2007, 18: 1131-1139
[33]
42 Bae Y, Nishiyama N, Fukushima S, et al. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: Tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjugate Chem, 2005, 16: 122-130
[34]
43 Zhan F, Chen W, Wang Z, et al. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release. Biomacromolecules, 2011, 12: 3612-3620
[35]
44 Zhou L, Cheng R, Tao H, et al. Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: Synthesis, drug release, and biodistribution in tumor-bearing mice. Biomacromolecules, 2011, 12: 1460-1467
[36]
1 Peer D, Karp J M, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol, 2007, 2: 751-760
[37]
2 Davis M E, Chen Z, Shin D M. Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat Rev Drug Discov, 2008, 7: 771-782
[38]
3 Deng C, Jiang Y, Cheng R, et al. Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: Promises, progress and prospects. Nano Today, 2012, 7: 467-480
[39]
4 Torchilin V P. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov, 2014, 13: 813-827
[40]
5 Egusquiaguirre P S, Igartua M, Hernandez R M, et al. Nanoparticle delivery systems for cancer therapy: Advances in clinical and preclinical research. Clin Transl Oncol, 2012, 14: 83-93
[41]
6 Kim T Y, Kim D W, Chung J Y, et al. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res, 2004, 10: 3708-3716
[42]
7 Matsumura Y, Hamaguchi T, Ura T, et al. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer, 2004, 91: 1775-1781
[43]
8 Kato K, Chin K, Yoshikawa T, et al. Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer. Invest New Drugs, 2012, 30: 1621-1627
[44]
9 Hamaguchi T, Doi T, Eguchi-Nakajima T, et al. Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors. Clin Cancer Res, 2010, 16: 5058-5066
[45]
10 Plummer R, Wilson R H, Calvert H, et al. A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. Br J Cancer, 2011, 104: 593-598
[46]
45 Gu Y, Zhong Y, Meng F, et al. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy. Biomacromolecules, 2013, 14: 2772-2780
[47]
46 Chen W, Meng F, Li F, et al. pH-responsive biodegradable micelles based on acid-labile polycarbonate hydrophobe: Synthesis and triggered drug release. Biomacromolecules, 2009, 10: 1727-1735
[48]
47 Steinhilber D, Witting M, Zhang X, et al. Surfactant free preparation of biodegradable dendritic polyglycerol nanogels by inverse nanoprecipitation for encapsulation and release of pharmaceutical biomacromolecules. J Control Release, 2013, 169: 289-295
[49]
48 Yang B, Lv Y, Zhu J Y, et al. A pH-responsive drug nanovehicle constructed by reversible attachment of cholesterol to PEGylated poly(L-lysine) via catechol-boronic acid ester formation. Acta Biomater, 2014, 10: 3686-3695
[50]
49 Li L, Bai Z, Levkin P A. Boronate-dextran: An acid-responsive biodegradable polymer for drug delivery. Biomaterials, 2013, 34: 8504-8510
[51]
50 Aguirre-Chagala Y E, Santos J L, Huang Y, et al. Phenylboronic acid-installed polycarbonate for pH-dependent release of diol-containing molecules. ACS Macro Lett, 2014, 3: 1249-1253
[52]
51 Meng F, Zhong Z. Polymersomes spanning from nano- to microscales: Advanced vehicles for controlled drug delivery and robust vesicles for virus and cell mimicking. J Phys Chem Lett, 2011, 2: 1533-1539
[53]
52 Lee J S, Feijen J. Polymersomes for drug delivery: Design, formation and characterization. J Control Release, 2012, 161: 473-483
[54]
53 Meng F, Zhong Z, Feijen J. Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules, 2009, 10: 197-209
[55]
54 Li M H, Keller P. Stimuli-responsive polymer vesicles. Soft Matter, 2009, 5: 927-937
[56]
55 Feng A, Yuan J. Smart nanocontainers: Progress on novel stimuli-responsive polymer vesicles. Macromol Rapid Commun, 2014, 35: 767-779
[57]
56 Chen W, Meng F, Cheng R, et al. pH-sensitive degradable polymersomes for triggered release of anticancer drugs: A comparative study with micelles. J Control Release, 2010, 142: 40-46
[58]
57 Yin H, Kang H C, Huh K M, et al. Biocompatible, pH-sensitive AB(2) miktoarm polymer-based polymersomes: Preparation, characterization, and acidic pH-activated nanostructural transformation. J Mater Chem, 2012, 22: 19168-19178
[59]
58 Choucair A, Soo P L, Eisenberg A. Active loading and tunable release of doxorubicin from block copolymer vesicles. Langmuir, 2005, 21: 9308-9313
[60]
59 Li S, Meng F, Wang Z, et al. Biodegradable polymersomes with an ionizable membrane: Facile preparation, superior protein loading, and endosomal pH-responsive protein release. Eur J Pharm Biopharm, 2012, 82: 103-111
[61]
60 Gubernator J. Active methods of drug loading into liposomes: Recent strategies for stable drug entrapment and increased in vivo activity. Expert Opin Drug Deliv, 2011, 8: 565-580
[62]
61 Sanson C, Schatz C, Le Meins J F, et al. A simple method to achieve high doxorubicin loading in biodegradable polymersomes. J Control Release, 2010, 147: 428-435
[63]
62 Liu G, Ma S, Li S, et al. The highly efficient delivery of exogenous proteins into cells mediated by biodegradable chimaeric polymersomes. Biomaterials, 2010, 31: 7575-7585
[64]
63 Du Y, Chen W, Zheng M, et al. pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride. Biomaterials, 2012, 33: 7291-7299
[65]
64 Meng F, Hennink W E, Zhong Z. Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials, 2009, 30: 2180-2198
[66]
65 Cheng R, Feng F, Meng F, et al. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J Control Release, 2011, 152: 2-12
[67]
66 Sun H, Meng F, Cheng R, et al. Reduction-responsive polymeric micelles and vesicles for triggered intracellular drug release. Antioxid Redox Signal, 2014, 21: 755-767
[68]
67 Sun H, Guo B, Cheng R, et al. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials, 2009, 30: 6358-6366
[69]
68 Sun H, Guo B, Li X, et al. Shell-sheddable micelles based on dextran-SS-poly(epsilon-caprolactone) diblock copolymer for efficient intracellular release of doxorubicin. Biomacromolecules, 2010, 11: 848-854
[70]
69 Tang L Y, Wang Y C, Li Y, et al. Shell-detachable micelles based on disulfide-linked block copolymer as potential carrier for intracellular drug delivery. Bioconjugate Chem, 2009, 20: 1095-1099
[71]
70 Wang Y C, Wang F, Sun T M, et al. Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells. Bioconjugate Chem, 2011, 22: 1939-1945
[72]
71 Wen H Y, Dong H Q, Xie W J, et al. Rapidly disassembling nanomicelles with disulfide-linked PEG shells for glutathione-mediated intracellular drug delivery. Chem Commun, 2011, 47: 3550-3552
[73]
72 Li J, Huo M, Wang J, et al. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials, 2012, 33: 2310-2320
[74]
73 Wang W, Sun H, Meng F, et al. Precise control of intracellular drug release and anti-tumor activity of biodegradable micellar drugs via reduction-sensitive shell-shedding. Soft Matter, 2012, 8: 3949-3956
[75]
75 Liu J, Huang W, Pang Y, et al. Molecular self-assembly of a homopolymer: An alternative to fabricate drug-delivery platforms for cancer therapy. Angew Chem Int Ed, 2011, 50: 9162-9166
[76]
76 Sun P, Zhou D, Gan Z. Novel reduction-sensitive micelles for triggered intracellular drug release. J Control Release, 2011, 155: 96-103
[77]
77 Wang X, Sun H, Meng F, et al. Galactose-decorated reduction-sensitive degradable chimaeric polymersomes as a multifunctional nanocarrier to efficiently chaperone apoptotic proteins into hepatoma cells. Biomacromolecules, 2013, 14: 2873-2882
[78]
78 Cheng R, Meng F, Deng C, et al. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials, 2013, 34: 3647-3657
[79]
79 Chen W, Zhong P, Meng F, et al. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release. J Control Release, 2013, 169: 171-179
[80]
80 Wei C, Guo J, Wang C. Dual stimuli-responsive polymeric micelles exhibiting “AND” logic gate for controlled release of adriamycin. Macromol Rapid Commun, 2011, 32: 451-455
[81]
81 Hu X, Li H, Luo S, et al. Thiol and pH dual-responsive dynamic covalent shell cross-linked micelles for triggered release of chemotherapeutic drugs. Polym Chem, 2013, 4: 695-706
[82]
82 Chen W, Achazi K, Schade B, et al. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release. J Control Release, 2015, 205: 15-24
[83]
83 Zhang J, Wu L, Meng F, et al. pH and reduction dual-bioresponsive polymersomes for efficient intracellular protein delivery. Langmuir, 2012, 28: 2056-2065
[84]
84 Du J Z, Du X J, Mao C Q, et al. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. J Am Chem Soc, 2011, 133: 17560-17563
[85]
85 Qiao Z Y, Zhang R, Du F S, et al. Multi-responsive nanogels containing motifs of ortho ester, oligo(ethylene glycol) and disulfide linkage as carriers of hydrophobic anti-cancer drugs. J Control Release, 2011, 152: 57-66
[86]
86 Cajot S, Lautram N, Passirani C, et al. Design of reversibly core cross-linked micelles sensitive to reductive environment. J Control Release, 2011, 152: 30-36
[87]
87 Pan Y J, Chen Y Y, Wang D R, et al. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release. Biomaterials, 2012, 33: 6570-6579
[88]
88 Xing T, Lai B, Ye X, et al. Disulfide core cross-linked PEGylated polypeptide nanogel prepared by a one-step ring opening copolymerization of N-carboxyanhydrides for drug delivery. Macromol Biosci, 2011, 11: 962-969
[89]
89 Ding J, Shi F, Xiao C, et al. One-step preparation of reduction-responsive poly(ethylene glycol)-poly (amino acid)s nanogels as efficient intracellular drug delivery platforms. Polym Chem, 2011, 2: 2857-2864
[90]
90 Xu H, Meng F, Zhong Z. Reversibly crosslinked temperature-responsive nano-sized polymersomes: Synthesis and triggered drug release. J Mater Chem, 2009, 19: 4183-4190
[91]
91 Cheng R, Meng F, Ma S, et al. Reduction and temperature dual-responsive crosslinked polymersomes for targeted intracellular protein delivery. J Mater Chem, 2011, 21: 19013-19020
[92]
92 Sun J, Chen X, Lu T, et al. Formation of reversible shell cross-linked micelles from the biodegradable amphiphilic diblock copolymer poly(L-cysteine)-block-poly(L-lactide). Langmuir, 2008, 24: 10099-10106
[93]
93 Wang Y C, Li Y, Sun T M, et al. Core-shell-corona micelle stabilized by reversible cross-linkage for intracellular drug delivery. Macromol Rapid Commun, 2010, 31: 1201-1206
[94]
94 Yan L, Wu W, Zhao W, et al. Reduction-sensitive core-cross-linked mPEG-poly(ester-carbonate) micelles for glutathione-triggered intracellular drug release. Polym Chem, 2012, 3: 2403-2412
[95]
95 Dai J, Lin S, Cheng D, et al. Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release. Angew Chem Int Ed, 2011, 50: 9404-9408
[96]
96 Li Y, Xiao K, Luo J, et al. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. Biomaterials, 2011, 32: 6633-6645
[97]
97 Ryu J H, Chacko R T, Jiwpanich S, et al. Self-cross-linked polymer nanogels: A versatile nanoscopic drug delivery platform. J Am Chem Soc, 2010, 132: 17227-17235
[98]
98 Sun H, Meng F, Cheng R, et al. Reduction and pH dual-bioresponsive crosslinked polymersomes for efficient intracellular delivery of proteins and potent induction of cancer cell apoptosis. Acta Biomater, 2014, 10: 2159-2168
[99]
99 Xu Y, Meng F, Cheng R, et al. Reduction-sensitive reversibly crosslinked biodegradable micelles for triggered release of doxorubicin. Macromol Biosci, 2009, 9: 1254-1261
[100]
100 Li Y L, Zhu L, Liu Z, et al. Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. Angew Chem Int Ed, 2009, 48: 9914-9918
[101]
101 Wei R, Cheng L, Zheng M, et al. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release. Biomacromolecules, 2012, 13: 2429-2438
[102]
102 Wu L, Zou Y, Deng C, et al. Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions. Biomaterials, 2013, 34: 5262-5272
[103]
103 Yu S, Ding J, He C, et al. Disulfide cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapy. Adv Healthcare Mater, 2014, 3: 752-760
[104]
104 Lee S J, Min K H, Lee H J, et al. Ketal cross-linked poly(ethylene glycol)-poly(amino acid)s copolymer micelles for efficient intracellular delivery of doxorubicin. Biomacromolecules, 2011, 12: 1224-1233
[105]
105 Wu Y, Chen W, Meng F, et al. Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma. J Control Release, 2012, 164: 338-345
[106]
106 Li Y, Xiao W, Xiao K, et al. Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols. Angew Chem Int Ed, 2012, 51: 2864-2869
[107]
107 Zhong Y, Meng F, Deng C, et al. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy. Biomacromolecules, 2014, 15: 1955-1969
[108]
108 Zhong Y, Yang W, Sun H, et al. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells. Biomacromolecules, 2013, 14: 3723-3730
[109]
109 Chen W, Zou Y, Meng F, et al. Glyco-nanoparticles with sheddable saccharide shells: A unique and potent platform for hepatoma-targeting delivery of anticancer drugs. Biomacromolecules, 2014, 15: 900-907
[110]
110 Zou Y, Song Y, Yang W, et al. Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice. J Control Release, 2014, 193: 154-161
[111]
111 Zhong Y, Zhang J, Cheng R, et al. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. J Control Release, 2015, 205: 144-154
[112]
112 Nasongkla N, Shuai X, Ai H, et al. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed, 2004, 43: 6323-6327
[113]
113 Zhong Y, Wang C, Cheng L, et al. Gold nanorod-cored biodegradable micelles as a robust and remotely controllable doxorubicin release system for potent inhibition of drug-sensitive and -resistant cancer cells. Biomacromolecules, 2013, 14: 2411-2419
[114]
114 Zhong Y, Wang C, Cheng R, et al. cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo. J Control Release, 2014, 195: 63-71
[115]
115 Wang Y, Yang T, Wang X, et al. Materializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle system. J Control Release, 2011, 149: 299-306
[116]
116 Zhu Z, Xie C, Liu Q, et al. The effect of hydrophilic chain length and iRGD on drug delivery from poly(epsilon-caprolactone)- poly(N-vinylpyrrolidone) nanoparticles. Biomaterials, 2011, 32: 9525-9535
